Tag: Rare diseases

The human body's immune system contains a complex network of proteins known as the complement system, where **C1 esterase inhibitor** plays a crucial role in regulating inflammation. This protein, which is often referred to by several other names in the medical community, is vital for preventing life-threatening swelling attacks in patients with a specific genetic disorder.

Every year, pharmaceutical companies process millions of liters of donated human plasma to create vital, life-saving medicines. This specialized and complex manufacturing process, known as fractionation, enables the extraction of essential proteins to produce therapies for a wide array of rare, chronic, and life-threatening conditions.

According to the Plasma Protein Therapeutics Association, plasma-derived therapies are critical for many rare and chronic diseases. We delve into **what drugs are made out of plasma**, a process where donated plasma is fractionated to create life-saving medicines like immunoglobulins and clotting factors.

As a global pharmaceutical leader with a vast portfolio of medicines and vaccines, Pfizer operates across numerous therapeutic areas, impacting millions of lives. Discovering what diseases does Pfizer treat reveals a commitment to addressing some of the most complex health challenges of our time, from common infections to rare genetic conditions.

Accounting for a disproportionately large share of total drug spending—often over 50% despite representing a small fraction of prescriptions—specialty drugs are a critical and growing area of modern medicine. This guide helps answer the complex question: **Which drugs are considered specialty drugs?**

Globally, the demand for plasma-derived therapies is steadily increasing, with some regions experiencing growth rates of 8–9% per year prior to the COVID-19 pandemic. These life-saving treatments, known as plasma-derived medicines, are crucial for patients with a variety of chronic, rare, and complex diseases.

According to several health insurance and pharmacy benefit managers, Orladeyo has been designated a specialty medication. For individuals with hereditary angioedema (HAE), understanding the classification of 'is orladeyo a specialty drug?' is crucial, as this designation significantly impacts the medication's cost, distribution, and the supportive services available to them.

Millions of patients worldwide depend on plasma-derived therapies for survival and improved quality of life. Answering the question, **what medicine is made from plasma?**, involves understanding how donated human plasma is processed into critical treatments for numerous rare and chronic conditions.

First documented for medical use in the 1920s for treating metal poisoning, sodium thiosulfate has a long history and is still used today to manage several rare but serious medical conditions. Its versatility as a therapeutic agent spans from emergency applications to managing chronic disorders. This article explores the various pharmacological applications of sodium thiosulfate.

Treating Cushing's disease often involves specialized medications, and the cost can be a significant concern for patients. Understanding **how much Isturisa costs** is crucial for those considering or currently undergoing treatment with this specific drug (osilodrostat). This article delves into the various facets of its pricing.